PE118999A1 - Composiciones y metodos para tratar trastornos respiratorios - Google Patents
Composiciones y metodos para tratar trastornos respiratoriosInfo
- Publication number
- PE118999A1 PE118999A1 PE1998000885A PE00088598A PE118999A1 PE 118999 A1 PE118999 A1 PE 118999A1 PE 1998000885 A PE1998000885 A PE 1998000885A PE 00088598 A PE00088598 A PE 00088598A PE 118999 A1 PE118999 A1 PE 118999A1
- Authority
- PE
- Peru
- Prior art keywords
- compositions
- methods
- respiratory disorders
- treating respiratory
- hydroxydiphenylmethyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000023504 respiratory system disease Diseases 0.000 title 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- SYTBZMRGLBWNTM-JTQLQIEISA-N (S)-flurbiprofen Chemical compound FC1=CC([C@@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-JTQLQIEISA-N 0.000 abstract 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010028735 Nasal congestion Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000000954 anitussive effect Effects 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- 229960005430 benoxaprofen Drugs 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- -1 cetirizine Chemical compound 0.000 abstract 1
- 229960001803 cetirizine Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 abstract 1
- 230000003419 expectorant effect Effects 0.000 abstract 1
- 229960002390 flurbiprofen Drugs 0.000 abstract 1
- 229960001680 ibuprofen Drugs 0.000 abstract 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
CARACTERIZADO PORQUE COMPRENDE a)UN ANALGESICO TAL COMO NAPROXENO O EL ENANTIOMERO S(+)-QUETOPROFENO, LISINATO, S(+)-IBUPROFENO; b)UN ANTIHISTAMINICO TAL COMO CETIRIZINA, METILO-4-[1-HIDROXIDIFENILMETILO-1-PIPERIDINILO)BUTILO]-O,O-DIMETILBENZINOACETATO, ACIDO 4-[1-HIDROXI-4-(4-HIDROXIDIFENILMETILO-1-PIPERIDINILO)BUTILO]-O,O-DIMETILBENZINOACETICO, ENTRE OTROS. LA COMPOSICION PUEDE COMPRENDER ADEMAS a)OTRO AGENTE ANALGESICO TAL COMO IBUPROFENO , BENOXAPROFENO, FLURBIPROFENO, ENTRE OTROS; b)UN DESCONGESTIONANTE; c)UN EXPECTORANTE; d)UN ANTITUSIVO; e)UN COMPUESTO AGONISTA-O, CAFEINA. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE LA TOS, RESFRIADO, SINTOMAS PARECIDOS AL RESFRIADO, CONGESTION NASAL, SINUSITIS, DOLOR
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93403397A | 1997-09-19 | 1997-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE118999A1 true PE118999A1 (es) | 2000-02-03 |
Family
ID=25464848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000885A PE118999A1 (es) | 1997-09-19 | 1998-09-17 | Composiciones y metodos para tratar trastornos respiratorios |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1014983A1 (es) |
| JP (1) | JP2001517626A (es) |
| KR (1) | KR20010024187A (es) |
| CN (1) | CN1278728A (es) |
| AU (1) | AU8744398A (es) |
| BR (1) | BR9812660A (es) |
| CA (1) | CA2304005A1 (es) |
| CO (1) | CO5011084A1 (es) |
| HU (1) | HUP0004813A2 (es) |
| NO (1) | NO20001412D0 (es) |
| PE (1) | PE118999A1 (es) |
| WO (1) | WO1999015173A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2419653A1 (en) * | 2000-09-08 | 2002-03-14 | Warner-Lambert Company | Prevention of acute sinusitis and sinus attack |
| MXPA03011705A (es) * | 2001-06-20 | 2004-03-19 | Schering Corp | Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal. |
| US6863901B2 (en) | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
| US7166641B2 (en) * | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| US7863287B2 (en) | 2002-12-18 | 2011-01-04 | Wyeth Llc | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| FR2865648B1 (fr) * | 2004-02-03 | 2006-06-30 | Philippe Perovitch | Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede |
| US20050192355A1 (en) * | 2004-02-17 | 2005-09-01 | Wyeth | Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines |
| CN101073563B (zh) * | 2007-02-07 | 2010-10-06 | 西安利君制药有限责任公司 | 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片 |
| GB0719518D0 (en) * | 2007-10-05 | 2007-11-14 | Therapeutics Ltd E | Therapy |
| WO2010078541A1 (en) * | 2009-01-05 | 2010-07-08 | Mcneil-Ppc, Inc. | Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen |
| US8377475B2 (en) | 2009-01-05 | 2013-02-19 | Mcneil-Ppc, Inc. | Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer |
| CA2748783A1 (en) | 2009-01-05 | 2010-07-08 | Mcneil-Ppc, Inc. | Three layer tablet containing cetirizine, pseudoephedrine, and naproxen |
| GB0905954D0 (en) * | 2009-04-06 | 2009-05-20 | E Therapeutics Plc | Treatment of exacerbations of asthma |
| CN103446587A (zh) * | 2011-12-28 | 2013-12-18 | 汪明 | 肥大细胞抑制剂在制备抗流感病毒感染药物中的应用 |
| CN103251590B (zh) * | 2013-05-13 | 2014-12-17 | 中国科学院武汉病毒研究所 | 一种琥珀酸多西拉敏在制备治疗或预防流感病毒药物中的应用 |
| ES2926494T3 (es) * | 2015-03-26 | 2022-10-26 | Sen Jam Pharmaceutical Llc | Combinación de naproxeno y fexofenadina para inhibir los síntomas asociados con veisalgia |
| CN109464670B (zh) * | 2017-09-08 | 2022-08-02 | 中国科学院微生物研究所 | 调控a型和b型流感病毒核蛋白出核的关键氨基酸位点及其作为抗流感病毒药物靶点的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783465A (en) * | 1984-04-09 | 1988-11-08 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
| US4871733A (en) * | 1984-04-09 | 1989-10-03 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
| US5260073A (en) * | 1990-05-21 | 1993-11-09 | Norwich Eaton Pharmaceuticals, Inc. | Use of phenylpropanolamine as a mucus secretogogue in the upper airways |
| CA2170488A1 (en) * | 1993-09-07 | 1995-03-16 | Sekhar Mitra | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| CA2227958A1 (en) * | 1995-07-28 | 1997-02-13 | Sekhar Mitra | Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| US5648358A (en) * | 1996-03-05 | 1997-07-15 | Mitra; Sekhar | Compositions and methods for treating respiratory disorders |
-
1998
- 1998-08-28 EP EP98938852A patent/EP1014983A1/en not_active Withdrawn
- 1998-08-28 CA CA002304005A patent/CA2304005A1/en not_active Abandoned
- 1998-08-28 KR KR1020007002958A patent/KR20010024187A/ko not_active Withdrawn
- 1998-08-28 WO PCT/IB1998/001339 patent/WO1999015173A1/en not_active Ceased
- 1998-08-28 CN CN98811202A patent/CN1278728A/zh active Pending
- 1998-08-28 AU AU87443/98A patent/AU8744398A/en not_active Abandoned
- 1998-08-28 JP JP2000512542A patent/JP2001517626A/ja not_active Withdrawn
- 1998-08-28 HU HU0004813A patent/HUP0004813A2/hu unknown
- 1998-08-28 BR BR9812660-1A patent/BR9812660A/pt not_active Application Discontinuation
- 1998-09-17 PE PE1998000885A patent/PE118999A1/es not_active Application Discontinuation
- 1998-09-21 CO CO98054352A patent/CO5011084A1/es unknown
-
2000
- 2000-03-17 NO NO20001412A patent/NO20001412D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999015173A1 (en) | 1999-04-01 |
| AU8744398A (en) | 1999-04-12 |
| KR20010024187A (ko) | 2001-03-26 |
| JP2001517626A (ja) | 2001-10-09 |
| CN1278728A (zh) | 2001-01-03 |
| EP1014983A1 (en) | 2000-07-05 |
| HUP0004813A2 (hu) | 2001-08-28 |
| BR9812660A (pt) | 2000-08-22 |
| CA2304005A1 (en) | 1999-04-01 |
| NO20001412D0 (no) | 2000-03-17 |
| CO5011084A1 (es) | 2001-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE118999A1 (es) | Composiciones y metodos para tratar trastornos respiratorios | |
| EP1428821A8 (en) | Piperidin-4-yl amines with analgesic effect | |
| BR9914251A (pt) | Formulações orais de liberação sustentada | |
| GEP20022636B (en) | 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2 | |
| PE20001032A1 (es) | Composiciones y metodos para tratar enfermedades pulmonares | |
| DE60140693D1 (en) | Ankheiten | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| CO5560558A2 (es) | Uso de una composicion de celecoxib para rapido alivio del dolor | |
| ES2001391A6 (es) | Procedimiento de obtencion de una composicion farmaceutica para el tratamiento de senos faciales y nasales, alergias y sintomas de resfriado. | |
| EP1007556A4 (en) | TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS | |
| TW200510375A (en) | New compounds | |
| EA200700232A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
| BG104315A (en) | Prostaglandine agonists and their application for the treatment of osteal diseases | |
| BR9810773A (pt) | Uso de um ingrediente anestésico local de ação prolongada, composição farmacêutica, uso de um anestésico local, e, kit | |
| BR9711194A (pt) | Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer. | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| DE69532031D1 (de) | Schilddrüsenhormone enthaltende mittel | |
| BR0014003A (pt) | Tratamento de combinação com compostos de diaril sufonil uréia e il-1ra | |
| CL2009001279A1 (es) | Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03). | |
| BR9809022A (pt) | Composições antiinflamatórias nasais tópicas | |
| BR9914158A (pt) | Composição antibiótica para o tratamento dos olhos, ouvidos e nariz | |
| BR9712705A (pt) | Composição para o tratamento da asma, contendo loratadina e um descongestionante | |
| PT1051159E (pt) | Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose | |
| BR0114395A (pt) | Composição farmacêutica para administração por suprimento via oral | |
| UA37278C2 (uk) | Протикашльова фармацевтична композиція для перорального введення |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |